[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Sanara Medtech Inc (SMTI)

Sanara Medtech Inc (SMTI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sanara Medtech Inc 1200 Summit Avenue Suite 414 Fort Worth TX 76102 USA

www.sanaramedtech.com Employees: 108 P: 817-529-2300

Sector:

Medical

Description:

Wound Management Technologies Inc. develops and markets wound care products. It develops, markets and distributes biotechnology products to physicians, hospitals and clinics. The Company markets collagen-based products for the treatment of pressure ulcers, diabetic ulcers, surgical wounds, ulcers due to arterial insufficiency, traumatic wounds, first and second degree burns and superficial wounds. It sells and distributes CellerateRX(R) Surgical Activated Collagen(R) Adjuvant as well as HemaQuell(R) Resorbable Bone Hemostat. Wound Management Technologies Inc. is based in Fort Worth, Texas.

Key Statistics

Overview:

Market Capitalization, $K 317,721
Enterprise Value, $K 347,111
Shares Outstanding, K 9,188
Float, K 5,329
% Float 58.00%
Short Interest, K 216
Short Float 2.35%
Days to Cover 1.00
Short Volume Ratio 0.53
% of Insider Shareholders 42.00%
% of Institutional Shareholders 8.10%

Financials:

Annual Sales, $ 103,120 K
Annual Net Income, $ -37,560 K
Last Quarter Sales, $ 28,140 K
Last Quarter Net Income, $ -450 K
EBIT, $ 17,310 K
EBITDA, $ 21,540 K

Growth:

1-Year Return 2.49%
3-Year Return -7.02%
5-Year Return 0.70%
5-Year Revenue Growth 561.45%
5-Year Earnings Growth 115.79%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.05 on 08/11/26
Next Earnings Date 11/11/26
Earnings Per Share ttm 0.22
EPS Growth vs. Prev Qtr 25.00%
EPS Growth vs. Prev Year 121.74%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-100 on 05/10/19

SMTI Ratios

Ratio
Price/Earnings ttm 157.50
Price/Earnings forward 216.56
Price/Earnings to Growth N/A
Return-on-Equity % 29.72%
Return-on-Assets % 2.84%
Profit Margin % -36.42%
Debt/Equity 5.86
Price/Sales 3.09
Price/Cash Flow 58.28
Price/Book 40.02
Book Value/Share 0.87
Interest Coverage -0.94
60-Month Beta 1.13
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.